Systemic Bevacizumab for Recurrent Respiratory Papillomatosis

This lecture explores Recurrent Respiratory Papillomatosis (RRP), focusing on its causes, impacts, and treatment options—highlighting the emerging role of systemic Bevacizumab. Discussions cover its mechanism of action, clinical effectiveness, and safety profile, alongside its advantages compared to traditional therapies. Key topics include clinical outcomes, reduction in disease severity, improved patient quality of life, and economic implications. The session also addresses challenges such...